Clinical Trial Update: Berberine Improving Cognitive Impairments in Schizophrenia [NA]

View source ↗

Summary

Ongoing clinical trial in China evaluating whether berberine improves cognitive impairments associated with schizophrenia, sponsored by Tianjin Anding Hospital,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Berberine (berberine)

Snippet

Sponsor: Tianjin Anding Hospital | Conditions: Schizophrenia Therapeutics | NA | Status: ENROLLING_BY_INVITATION